Institutional investors purchased a net $1.5 million shares of THOR during the quarter ended September 2013 and now own 90.01% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAGLE ASSET MANAGEMENT, INC. Bought 2.2 Million shares of Thoratec Corp